Radiomics for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Observational Trial
Bioengineering · 24.05.2023 · 10 (6) · 634
DOI: 10.3390/bioengineering10060634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering, online erschienen am 24.05.2023. Verfasst von Liming Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310019, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese National Natural Science Foundation, Varian Medical Inc..
Abstract (Originalsprache)
(1)
Background
An increasing amount of research has supported the role of radiomics for predicting pathological complete response (pCR) to neoadjuvant chemoradiation treatment (nCRT) in order to provide better management of locally advanced rectal cancer (LARC) patients. However, the lack of validation from prospective trials has hindered the clinical adoption of such studies. The purpose of this study is to validate a radiomics model for pCR assessment in a prospective trial to provide informative insight into radiomics validation. (2)
Methods
This study involved a retrospective cohort of 147 consecutive patients for the development/validation of a radiomics model, and a prospective cohort of 77 patients from two institutions to test its generalization. The model was constructed using T2-weighted, diffusion-weighted, and dynamic contrast-enhanced MRI to understand the associations with pCR. The consistency of physicians’ evaluations and agreement on pathological complete response prediction were also evaluated, with and without the aid of the radiomics model. (3)
Results
The radiomics model outperformed both physicians’ visual assessments in the prospective test cohort, with an area under the curve (AUC) of 0.84 (95% confidence interval of 0.70–0.94). With the aid of the radiomics model, a junior physician could achieve comparable performance as a senior oncologist. (4)
Conclusion
We have built and validated a radiomics model with pretreatment MRI for pCR prediction of LARC patients undergoing nCRT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310019, China.
- Department of Radiation Oncology, Rutgers-Cancer Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School, 195 Little Albany St., New Brunswick, NJ 08903, USA.
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310019, China.
ORCID-Profile: Xiaonan Sun
Förderung
- Chinese National Natural Science Foundation
- Varian Medical Inc.
Zitieren
APA
Shi, L., Zhang, Y., Hu, J., Zhou, W., Hu, X., Cui, T., Yue, N. J., Sun, X., & Nie, K. (2023). Radiomics for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Observational Trial. Bioengineering, 10(6), 634. https://doi.org/10.3390/bioengineering10060634
Vancouver
Shi L, Zhang Y, Hu J, Zhou W, Hu X, Cui T, et al. Radiomics for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Observational Trial. Bioengineering. 2023;10(6):634. doi:10.3390/bioengineering10060634
BibTeX
@article{Shi2023,
author = {Shi, Liming and Zhang, Yang and Hu, Jiamiao and Zhou, Weiwen and Hu, Xi and Cui, Taoran and Yue, Ning J and Sun, Xiaonan and Nie, Ke},
title = {Radiomics for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Observational Trial},
journal = {Bioengineering},
year = {2023},
volume = {10},
number = {6},
pages = {634},
doi = {10.3390/bioengineering10060634}
}
EUVIMED